###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
CRY2 Is Associated with Depression
###end article-title 0
###begin p 1
Conceived and designed the experiments: CL TP MS. Performed the experiments: LS PS MV RA. Analyzed the data: CL LS PS TP MV WEB YF JW JK TP MS. Contributed reagents/materials/analysis tools: CL TP MV WEB RA YF JW JK TP MS. Wrote the paper: CL LS PS TP MV WEB RA YF JW JK TP MS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
Abnormalities in the circadian clockwork often characterize patients with major depressive and bipolar disorders. Circadian clock genes are targets of interest in these patients. CRY2 is a circadian gene that participates in regulation of the evening oscillator. This is of interest in mood disorders where a lack of switch from evening to morning oscillators has been postulated.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
We observed a marked diurnal variation in human CRY2 mRNA levels from peripheral blood mononuclear cells and a significant up-regulation (P = 0.020) following one-night total sleep deprivation, a known antidepressant. In depressed bipolar patients, levels of CRY2 mRNA were decreased (P = 0.029) and a complete lack of increase was observed following sleep deprivation. To investigate a possible genetic contribution, we undertook SNP genotyping of the CRY2 gene in two independent population-based samples from Sweden (118 cases and 1011 controls) and Finland (86 cases and 1096 controls). The CRY2 gene was significantly associated with winter depression in both samples (haplotype analysis in Swedish and Finnish samples: OR = 1.8, P = 0.0059 and OR = 1.8, P = 0.00044, respectively).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
We propose that a CRY2 locus is associated with vulnerability for depression, and that mechanisms of action involve dysregulation of CRY2 expression.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 318 321 318 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Germain1">[1]</xref>
###xml 376 379 376 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Yin1">[2]</xref>
###xml 567 570 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Faedda1">[3]</xref>
###xml 835 838 835 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Partonen1">[4]</xref>
###xml 935 938 935 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Rosenthal1">[5]</xref>
###xml 1065 1068 1065 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Partonen1">[4]</xref>
###xml 1307 1310 1307 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Kiesepp1">[6]</xref>
###xml 1557 1560 1557 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Bunney1">[7]</xref>
###xml 1562 1565 1562 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-McClung1">[8]</xref>
###xml 184 192 <span type="species:ncbi:261946|species:ncbi:501646|species:ncbi:34344|species:ncbi:526811|species:ncbi:338539|species:ncbi:369518">e. major</span>
Rhythms that approximate the 24-hour day-night cycle or light-dark transitions are called circadian. Abnormalities of the circadian pacemaker system is often seen in mood disorders (i.e. major depressive and bipolar disorders) as evidenced with sleep stage abnormalities and the clinical efficacy of sleep deprivation [1] as well as with the therapeutic mechanisms of lithium [2] that is prescribed primarily for bipolar disorder. Approximately one tenth of all mood disorders follow a seasonal pattern and area hence categorized as seasonal affective disorder (SAD) [3]. Season-bound mood episodes may occur in both depressive and bipolar disorders and emerge in any season, but the most common type is winter depression, a condition in which major depressive episodes routinely occur in the wintertime and remit the following summer [4]. In one study as much as 93% of the winter depression cases had a diagnosis of bipolar disorder [5] although other studies tend to show a greater proportion of unipolar recurrent major depression among winter depression cases [4]. Depressive episodes in winter depression are highly recurrent and appear to be clearly endogenous as there is no psychosocial factor that would account for their onset. For bipolar type 1 disorder, the heritability estimate is very high [6]. Therefore, winter depression, whether part of major depressive disorder or bipolar disorder, as well as bipolar type 1 disorder, with or without a seasonal pattern, provide excellent models for studying the molecular mechanisms of mood disorder [7], [8].
###end p 9
###begin p 10
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lewy1">[9]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Teicher1">[11]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Glod1">[12]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Czeisler1">[13]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Thompson1">[14]</xref>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Srinivasan1">[15]</xref>
###xml 935 939 935 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lamont1">[16]</xref>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">children</span>
###xml 669 677 <span type="species:ncbi:9606">patients</span>
###xml 794 802 <span type="species:ncbi:9606">patients</span>
###xml 904 912 <span type="species:ncbi:9606">patients</span>
###xml 1161 1169 <span type="species:ncbi:9606">patients</span>
Advances and delays in phase (the location within a cycle at a particular time) and reduced amplitudes (intensities of the oscillations) have been reported in adult patients [9]-[11], while children with winter depression have circadian rhythms that are accurate in phase but low in amplitude [12]. This agrees with the hypothesis that not only phase shifts but also amplitude attenuations [13] contribute to the pathogenesis, and suggests that there are circadian clockwork abnormalities having relevance to the daily reset and synchronization. This is further supported by findings of the seasonal changes in sensitivity to light exposure in winter depression, these patients having supersensitivity to light in terms of melatonin suppression during winter [14], abnormal melatonin levels in patients with seasonal or non-seasonal depressive disorder [15], and abnormalities in circadian alignments in patients with bipolar disorder [16]. Therefore, the internal misalignment (i.e. the sleep-wake cycle is no longer in phase with the circadian rhythms) may account for the pathogenesis of mood disorders in general. Light exposures and sleep manipulations in patients with mood disorder are tools for exploration and elucidation of the mechanisms driving the circadian and seasonal clockworks.
###end p 10
###begin p 11
###xml 13 17 13 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Hsu1">[17]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Kume1">[18]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Miyamoto1">[19]</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Luo1">[24]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Dardente1">[25]</xref>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
CRY proteins [17] differ from many transcription factors that take part in the circadian clockwork, since they have no PAS domains. This suggests that they are unique in the core of the circadian clockwork where they act [18]. Both CRY1 and CRY2 operate in the retina and non-visual light detection pathways in a manner that is important for the internal alignment [19]-[24]. Of these two, CRY2 is highly expressed in the brain in particular and has a dose-dependent inhibitory effect on the activated ARNTL, whereas both CRY2 and CRY1 repress all four combinations of the ARNTL (ARNTL2) - CLOCK (NPAS2) protein heterodimers that act as transcriptional activators in the core of the circadian clockwork [25]. These basic findings give a rationale for the CRY2 gene as a target of high interest and relevance in our study.
###end p 11
###begin p 12
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
Here, we assessed CRY2 gene expression in eight healthy volunteers for 48 hours and in 13 patients with bipolar disorder before and after a one-night sleep deprivation, and we report that CRY2 mRNA levels are reduced and unresponsive to sleep deprivation in depressed patients with bipolar disorder. To determine whether CRY2 genetic variation is associated with depression, we analyzed circadian clock gene variants in two separate population-based samples, a Swedish sample and a Finnish sample, and report that the CRY2 gene is associated with winter depression.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
CRY2 Expression Analysis
###end title 14
###begin p 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 195 203 195 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009407-g001">Figure 1</xref>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
CRY2 mRNA levels displayed marked diurnal variation in healthy controls (n = 8). In addition, total sleep deprivation induced a 2.0-fold increase in CRY2 mRNA levels (P = 0.020) in the controls (Figure 1). The control gene GAPDH mRNA levels did not show diurnal variation and were not changed by the effect of sleep deprivation (P = 0.66).
###end p 15
###begin title 16
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
CRY2 gene expression in healthy volunteers and bipolar disorder patients.
###end title 16
###begin p 17
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
CRY2 mRNA expression was not changed by sleep deprivation in bipolar disorder patients (triangle) and was significantly decreased compared to healthy volunteers (square) during sleep deprivation. Blood draw 1 (x-axis) was at 7 p.m., then there was a blood draw every 6 hours. Sleep deprivation was at time points #6, #7, #8 and #9. Bars indicate mean and error bars indicate SEM.
###end p 17
###begin p 18
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 411 419 <span type="species:ncbi:9606">patients</span>
In samples from patients in a depressive state of bipolar disorder (n = 13), sleep deprivation did not induce any increase in CRY2 mRNA levels. CRY2 mRNA expression was significantly decreased in the samples from patients as compared with the samples from healthy controls during sleep deprivation (P = 0.041 for the diagnosis and sleep deprivation interaction using ANOVA; P = 0.029 for the difference between patients and controls during sleep deprivation in post hoc test). GAPDH showed similar mRNA levels in the samples from controls to those in the bipolar disorder samples (P = 0.12).
###end p 18
###begin title 19
Genetic Association Analysis
###end title 19
###begin p 20
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 611 618 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009407-t001">Table 1</xref>
###xml 773 780 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009407-t002">Table 2</xref>
###xml 909 926 909 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009407-g002">Figures 2A and 2B</xref>
Analyses were performed on two samples of clinical cases with a diagnosis of winter depression (DSM-IV) and healthy screened controls (Swedish sample: 118 cases and 1011 controls, Finnish sample: 86 cases and 1096 controls). CRY2 allele frequency was significantly associated with winter depression in the Swedish sample, as shown with three SNPs (rs10838524 risk allele A, rs10838527 risk allele G, and rs3824872 risk allele A) having OR = 1.6, OR = 2.1 and OR = 1.8 (P = 0.0017, P = 0.00074 and 0.00070, respectively). The association to rs10838524 was confirmed in the Finnish sample (OR = 1.7, P = 0.0020) (Table 1) and indicated that homozygosity of the minor allele (overall minor allele frequency of about 0.5) was increased in the cases in both population samples (Table 2). The associated SNPs (rs10838527 and rs3824872) were present in LD block 1 (rs7123390, rs10838527, rs3824872) in both samples (Figures 2A and 2B).
###end p 20
###begin title 21
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
The suggested vulnerability locus in CRY2.
###end title 21
###begin p 22
LD structure of the SNPs analyzed in A) the Swedish sample, and B) the Finnish sample. C) Scheme of the suggested location of the functional variant in the Finnish sample, in the Swedish sample, and the common locus relevant under the assumption of the same functional variant in the two samples. An open end of locus box (seen for the Swedish sample) indicates that this is not the locus border. The numbers in the squares of A and B) represent the pair-wise D' value, empty squares stand for D' = 1. Pink-red color indicates a pair-wise LOD >/=2 with redness proportional to D'. Haplotype blocks are formed if 95% of comparisons are "strong LD", i.e. the 95% CI of D' is within [0.7-0.98].
###end p 22
###begin title 23
SNP allele frequency association analysis.
###end title 23
###begin p 24
Alleles, minor allele first.
###end p 24
###begin p 25
OR, proportion of minor versus major allele among affected (A)/proportion of minor versus major allele among non-affected (U).
###end p 25
###begin p 26
###xml 46 47 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Logistic regression with gender as covariate. P<0.05 are shown.
###end p 26
###begin p 27
No covariate.
###end p 27
###begin p 28
###xml 11 13 11 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-</italic>
Point-wise P-value from 10,000 permutations with no covariate (EMP1).
###end p 28
###begin p 29
Ancestral allele in CEU population data (CEPH (Utah residents with ancestry from northern and western Europe)) from .
###end p 29
###begin title 30
Genotype association analysis of the SNPs with suggestive allele frequency association.
###end title 30
###begin p 31
Allele 'a' is the minor allele.
###end p 31
###begin p 32
Note that the identity of the rs10838524 minor allele differs between the Swedish and Finnish samples.
###end p 32
###begin p 33
###xml 159 160 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 206 207 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 250 258 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009407.s001">Table S1</xref>
###xml 488 495 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009407-t003">Table 3</xref>
###xml 817 824 813 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009407-t003">Table 3</xref>
###xml 1582 1591 1578 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009407-g002">Figure 2C</xref>
Four haplotypes were identified and a significant difference in distribution of haplotypes between the cases and controls was found for the Swedish sample (chi2 = 8.7, P = 0.034) and the Finnish sample (chi2 = 14.6, P = 0.0022; see Supplemental data Table S1). A haplotype of the risk alleles GGA was more frequent in the Swedish cases compared with controls (OR = 1.7, P = 0.012) and even more so when adding the rs10838524 risk allele to the haplotype to be AGGA (OR = 1.8, P = 0.0059; Table 3). The block 1 (rs7123390, rs10838527, rs3824872) haplotype GAC which in the Swedish sample has the protective alleles from rs10838527 and rs3824872 was a risk haplotype in the Finnish sample (OR = 1.8, P = 0.00010), and similarly so when adding the rs10838524 allele G to the haplotype to be GGAC (OR = 1.8, P = 0.00044; Table 3). The Finnish data suggest a vulnerability locus increasing the risk for winter depression upstream rs10838527. This was further supported by the fact that changing only the rs7123390 allele in the Finnish risk haplotype (GAC) turned it into a protective haplotype (AAC) in the Finnish sample (OR = 0.61, P = 0.012), and the fact that the AGAC was non-existent of in the samples. Considering only the Swedish data the vulnerability locus could reside on either side of, but not exactly at rs7123390. If assuming the same functional variation (although probably opposite risk alleles in Swedes and Finns), the Swedish and the Finnish samples together hence suggest the vulnerability locus to reside in-between rs7123390 and rs10838527 or upstream rs7123390 (Figure 2C).
###end p 33
###begin title 34
Haplotype association analysis.
###end title 34
###begin p 35
Odds ratio (OR): the ratio specific haplotype versus all other haplotypes among the cases, relative to the ratio specific haplotype versus all other haplotypes among the controls.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lappalainen1">[26]</xref>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 944 948 944 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 1123 1130 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009407-g002">Fig. 2C</xref>
###xml 1166 1170 1166 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
Our key findings herein are that CRY2 gene variation and expression levels are associated with depression. CRY2 mRNA levels are lowered in blood mononuclear cells from depressed patients with bipolar disorder after total sleep deprivation in comparison to healthy controls, and CRY2 gene variation was associated with winter depression in both Swedish and Finnish patients. Differences in CRY2 risk haplotypes were observed between the Swedes and Finns. Overall there are genetic differences between these populations [26]. The fact that Swedes and Finns have different histories in terms of going through genetic bottle-necks that could have affected selection in operation at the CRY2 locus with regard to depression vulnerability, would possibly explain the differences in CRY2 risk haplotypes seen between the two samples, and explain a putative allelic heterogeneity (different vulnerability alleles in Swedes and Finns) of the functional CRY2 polymorphism. Assuming the same functional variant in the Swedish and the Finnish samples, the two samples would assist in narrowing the interval of that functional variant (Fig. 2C). The risk haplotypes spanned from CRY2 intron 1 to 3'UTR, and pointed at a location of a potential function variation somewhere upstream exon 12 in 3'UTR (rs10838527) from the Finnish data, with a distance from the intron 1 marker rs10838524 to rs10838527 corresponding to approximately33 kb (NCBI build 130). The vulnerability locus from the Swedish data overlapped the Finnish locus, but for at the intron 7 marker rs7123390, and extended downstream rs10838527.
###end p 37
###begin p 38
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Miyazaki1">[27]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Tsinkalovsky1">[28]</xref>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
Human CRY2 mRNA levels have been demonstrated to undergo circadian oscillation in fibroblasts [27] and in hematopoietic stem cells [28]. Our results herein add on these findings and demonstrate the effect of sleep deprivation on the circadian oscillations of CRY2 mRNA in human peripheral blood mononuclear cells. Our data indicate that depression in bipolar disorder is related to lowered levels of CRY2 mRNA. Sleep deprivation led to CRY2 mRNA increase in controls whereas depressed bipolar individuals were non-responsive.
###end p 38
###begin p 39
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Ozgur1">[29]</xref>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-UkaiTadenuma1">[30]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Zhang1">[32]</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Thresher1">[33]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Spoelstra1">[36]</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry2</italic>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Thompson2">[37]</xref>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per2</italic>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Liu1">[38]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Oster1">[39]</xref>
###xml 839 843 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per1</italic>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per2</italic>
###xml 904 908 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry1</italic>
###xml 913 917 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry2</italic>
###xml 946 950 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lincoln1">[40]</xref>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 1100 1104 1100 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Koorengevel1">[41]</xref>
###xml 1137 1141 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Elsass1">[42]</xref>
###xml 1166 1170 1166 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Daan1">[43]</xref>
###xml 1299 1303 1299 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry2</italic>
###xml 1387 1391 1387 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry1</italic>
###xml 1405 1409 1405 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Spoelstra1">[36]</xref>
###xml 1479 1483 1479 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Thompson3">[44]</xref>
###xml 1532 1536 1532 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Nurnberger1">[45]</xref>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 1068 1076 <span type="species:ncbi:9606">patients</span>
CRY2 has been purified from human cells and its properties have been described [29], but the understanding of CRY2 regulation and CRY2 functions still need elucidation. Earlier studies have demonstrated that CRY2 transcription is driven by the canonical circadian circuit but through a unique mechanism of action not yet characterized [30]-[32]. CRY2 is unique among the canonical genes of the circadian clock, since experimental findings of its effects on the circadian clockwork violate the predictions from a theory on the roles of PER1, PER2, CRY1 and CRY2 [33]-[36]. Deletion of Cry2 gene lengthened the circadian period by approximately 48 min (from 23.7 to 24.5 hours) [37] and in fact strengthened circadian amplitudes and restored the lost rhythms in Per2 mutant mice [38], [39]. These findings fit in the view that activation of Per1 and Per2 genes occurs in the morning, whereas activation of Cry1 and Cry2 genes occurs in the evening [40]. Abnormalities in CRY2 regulation would therefore leave the morning oscillator intact, which agrees with findings in patients with winter depression [41] and those with bipolar disorder [42]. However, disruption of CRY2 regulation may compromise the evening oscillator and the subsequent proper oscillator reactions to light-dark transitions [43]. Cry2 null mutants are less decelerated, or are more accelerated, by light exposure than Cry1 null mutants [36]. The former phenotype does match with that seen in winter depression [44] and, to some extent, in bipolar type 1 disorder [45].
###end p 39
###begin p 40
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry1/Cry2</italic>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lincoln1">[40]</xref>
###xml 272 281 272 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per1/Per2</italic>
###xml 285 294 285 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry1/Cry2</italic>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Srinivasan1">[15]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lamont1">[16]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Wehr1">[46]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Partonen2">[47]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lavebratt1">[48]</xref>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PER2</italic>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lewy2">[49]</xref>
###xml 791 795 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Teicher1">[11]</xref>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
The action of melatonin on Cry1/Cry2 expression is hypothesized to form the basis of refractory reactions to stimulation with light [40], and the subsequent subsensitive or supersensitive responses to light exposure. Phase control through the melatonin-guided interval of Per1/Per2 to Cry1/Cry2 expression peaks may have relevance to mood disorders, as the internal alignment and the melatonin signal (amplitude and phase) are abnormal in patients with bipolar disorder and those with winter depression in particular [15], [16], [46]. Our findings now suggest that a dawn component [47], [48] and a dusk component (herein), i.e. PER2 and CRY2 variants respectively, are affected in winter depression. Such influence may well contribute to phase angle differences [49] and entrainment errors [11] that have been found in patients with winter depression.
###end p 40
###begin p 41
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry2</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
To sum up, the phenotype of the Cry2 knockout mice together with mechanistic data are in line with the finding in this report suggesting that CRY2 has a role in winter depression.
###end p 41
###begin p 42
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Kanazawa1">[50]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-LeNiculescu1">[51]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Niculescu1">[52]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Ogden1">[53]</xref>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLOCK</italic>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Shi1">[54]</xref>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR1D1</italic>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PER3</italic>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Mansour1">[55]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Kripke1">[57]</xref>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RORA</italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RORB</italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RXRG</italic>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-LeNiculescu1">[51]</xref>
###xml 696 700 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PER2</italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPAS2</italic>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Partonen2">[47]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lavebratt1">[48]</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Johansson1">[58]</xref>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAOA</italic>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Hampp1">[59]</xref>
###xml 418 423 <span type="species:ncbi:9606">human</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
Our current findings add to earlier gene expression studies in blood that have reported a number of potential peripheral biomarkers for bipolar disorder [50], [51], and earlier gene expression findings in brain indicating that clock genes are implicated in a model of bipolar disorder, the first report being [52], followed by [53] for CRY2. Circadian genes with a polymorphism previously reported to be associated to human bipolar disorder include CLOCK[54], and NR1D1, ARNTL and PER3[55]-[57]. Moreover, ARNTL, RORA, RORB and RXRG were associated with bipolar disorder in a meta-analysis integrating data from genome-wide association studies and human and animal model expression studies [51]. PER2, NPAS2 and ARNTL genetic variation have been found associated with winter depression [47], [48], [58], and recent experimental data demonstrated these three proteins to regulate transcription of MAOA and to have subsequent influence on depressive behavior [59].
###end p 42
###begin p 43
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Nyholt1">[60]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Gao1">[61]</xref>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 590 598 <span type="species:ncbi:9606">patients</span>
Other circadian genes were tested for association to winter depression in parallel with CRY2. The CRY2 finding reached significance even after correction for multiple testing considering other circadian gene SNPs tested for association to winter depression in parallel with CRY2. The corrected threshold for significance corresponded to a nominal P-value of 0.001 and was calculated applying a Bonferroni correction considering the partial LD between markers [60], [61]. As a novel finding we report here that CRY2 expression is reduced and non-responsive to sleep deprivation in depressed patients with bipolar disorder, suggesting that CRY2 plays a role in bipolar disorder.
###end p 43
###begin p 44
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 751 754 751 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Yin1">[2]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Sprouse1">[62]</xref>
###xml 959 963 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
###xml 859 867 <span type="species:ncbi:9606">patients</span>
###xml 994 1002 <span type="species:ncbi:9606">patients</span>
###xml 1072 1080 <span type="species:ncbi:9606">patients</span>
There are some limitations in our work. A limitation in the CRY2 expression analysis was the few time points for the cases, since they do not allow analysis of the CRY2 rhythm and possible phase shift among the cases. However, irrespectively of whether there was a phase shift or not among the cases, CRY2 mRNA levels were significantly lower in cases compared to controls after sleep deprivation, which suggests that CRY2 levels is a trait marker that is non-responsive to the antidepressant sleep deprivation. Though, we cannot exclude that the CRY2 mRNA levels in the patients were influenced by medication. All the patients were on an SSRI together with a mood stabilizer. Lithium is known to affect the circadian clock through inhibition of GSK3 [2], and there are reports of SSRI influencing the circadian rhythms [62]. Since all controls and 10 of the patients were studied during the summer, the season of the examinations does not likely explain the CRY2 mRNA level difference between patients and controls. A limitation in the genetic analysis was the number of patients. However, the cases and the controls in both the Swedish and the Finnish materials represented ethnically homogeneous populations, and the controls were extensively scored to exclude any mental illness, reducing bias due to the ethnic variation and dilution of genetic effects due to disorder heterogeneity among the controls.
###end p 44
###begin p 45
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
In conclusion, we show data suggesting that variation in CRY2 links to depression. CRY2 mRNA expression levels were lowered in PBMCs from depressed patients with bipolar disorder. In two ethnically homogeneous population-based samples, CRY2 SNPs were associated with winter depression. Although this study contains a replication of the genetic findings, it remains limited due to the lack of replication of the expression findings, thus warranting further studies.
###end p 45
###begin title 46
Methods
###end title 46
###begin title 47
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
CRY2 Expression Study
###end title 47
###begin p 48
###xml 40 51 <span type="species:ncbi:9606">participant</span>
Informed consent was obtained from each participant using an approved University of California Institutional Review Board (IRB) protocol.
###end p 48
###begin p 49
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Hamilton1">[63]</xref>
###xml 849 857 849 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009407-g002">Figure 2</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 22 25 <span type="species:ncbi:9606">men</span>
###xml 29 34 <span type="species:ncbi:9606">women</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 512 517 <span type="species:ncbi:9606">women</span>
###xml 521 524 <span type="species:ncbi:9606">men</span>
###xml 642 650 <span type="species:ncbi:9606">patients</span>
###xml 892 900 <span type="species:ncbi:9606">patients</span>
###xml 994 1002 <span type="species:ncbi:9606">patients</span>
Thirteen patients (10 men, 3 women, out of which 11 with European, one with Asian and one with African decent) with bipolar type 1 disorder according to DSM-IV criteria, aged 40.2 years on average (SD = 13.4, range = 18-57), were enrolled in a sleep deprivation study at University of California Irvine (UCI) and San Diego (UCSD). During the study, all the patients were depressed, with the score on the 21-item Hamilton Depression Rating Scale [63] being 17.3 (SD = 6.4) on average. Eight healthy volunteers (4 women, 4 men, all with European decent), aged 23.6 years on average (SD = 5.9, range = 19-34 years), served as controls. Both the patients and the controls were hospitalized at the sleep research center at University of California at Irvine Medical Center (UCIMC) for 48 hours and deprived of sleep for 21 hours after an overnight stay (Figure 2). The season for the study of the patients was summer (n = 10) and winter (n = 3), and all controls were studied in the summer. All the patients were on an SSRI and either lithium (n = 8), valproate (n = 1) or lamotrigine (n = 4). None of the controls was on medication.
###end p 49
###begin p 50
###xml 842 847 842 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 927 934 927 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
###xml 1071 1075 1071 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 1080 1085 1080 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1206 1210 1206 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 1215 1220 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 290 297 <span type="species:ncbi:9606">patient</span>
###xml 1005 1013 <span type="species:ncbi:9606">patients</span>
For the controls, venous blood samples were drawn at 9 different times, beginning at 7 p.m. and every 6 hours thereafter. For the patients, the blood was drawn at 1 p.m. on the days before and after sleep deprivation, corresponding to the time points #4 and #8 for the control samples. The patient blood was drawn in standard Vacutainer tubes without additive (10 ml, Becton Dickinson, Franklin Lakes, NJ, USA). From each control the blood was collected into both a standard acid citrate dextrose (ACD) tube (Becton Dickinson, Franklin Lakes, NJ, USA) as well as a Tempus Blood RNA Tube (Applied Biosystems, Foster City, CA, USA) in the same blood draw, yielding the total of 25-35 ml of whole blood. To check for potential difference in RNA degradation between control and bipolar disorder samples, the level of the house-keeping transcript GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was analyzed with qPCR (data in the results section). To further rule out possible bias in comparison between the patients and controls due to type of collection tube, we compared CRY2 and GAPDH mRNA levels using qPCR between the Tempus tube and the ACD tube from the controls collected at the same blood draw. The CRY2 and GAPDH mRNA levels were not different between tube types (data not shown).
###end p 50
###begin title 51
Peripheral Blood Mononuclear Cells (PBMC) Isolation and RNA Extraction
###end title 51
###begin p 52
###xml 26 34 <span type="species:ncbi:9606">patients</span>
All samples from both the patients and the controls were prepared similarly. Within a few minutes in room temperature after blood draw, the whole blood samples were layered onto Ficoll (Amersham Biosciences, Piscataway, NJ, USA), and PBMC were separated by density gradient centrifugation at 2500 rpm at room temperature for 20 min. The resulting 'buffy' coat at the interface was added to 5 ml phosphate buffered saline (PBS) at pH of 7.4 (Invitrogen, Carlsbad, CA, USA) and cell counts were taken. Cells were centrifuged at 1000 rpm for 10 min at room temperature. The resulting pellets were resuspended in 1 ml Trizol and stored at minus 80degreesC. Total RNA was extracted using the standard Trizol isolation protocol (Invitrogen, Carlsbad, CA, USA). The RNA was resuspended in 50 microL DEPC water, cleaned by passing over silica-based mini-spin columns (Qiagen RNeasy PlusMini Kit, Valencia, CA, USA) and analyzed for quality and quantity on a 2100 Bioanalyzer (Agilent, Palo Alto, CA, USA) and concentration was adjusted to 1 microg/microl.
###end p 52
###begin title 53
Real Time Quantitative PCR (qPCR)
###end title 53
###begin p 54
###xml 144 146 140 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 1168 1172 1092 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 1310 1336 1234 1260 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTACCTGCGCTTTGGTTGT-3&#8242;</named-content>
###xml 1346 1372 1270 1296 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCTGTTCCGCTTCACCTTT-3&#8242;</named-content>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
The total RNA (1 microg RNA) from both the patients and the controls were identically synthesized into complementary DNA (cDNA) using Oligo d(T)16 primer and TaqMan Reverse Transcription Reagents and (Applied Biosystems, Foster City, CA, USA) at 25degreesC for 10 min, 48degreesC for 30 min and 95degreesC for 5 min. The quantitative PCR (qPCR) was performed on an ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA) with triplicates for each cDNA, using Robot Biomek3000 (Beckman Coulter, Fullerton, CA, USA), with all samples run in the same plates with same normalization procedures. The reaction was performed in 12.5 microl consisting of 6.25 microl 2xSYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA); 2.5 pmol of each primer; 2 microl 1:10 dilution of cDNA template (corresponding approximately to 4 ng RNA). The thermal cycling profiles were 50degreesC for 2 min (incubation), 95degreesC for 10 min (activation), 45 cycles at 95degreesC for 15 sec (denaturation) and 60degreesC for 1 min (annealing/extension), then by dissociation step as 95degreesC for 15 sec, 60degreesC for 15 sec, and 95degreesC for 15 sec. The CRY2 primer sequences spanned exon 6-7 junction within target sequence (Affymetrix probeset 3329058, transcript ID 3329029) and were: forward 5'-CCTACCTGCGCTTTGGTTGT-3', reverse 5'-TGCTGTTCCGCTTCACCTTT-3'. The primers were pre-tested using brain cDNA, genomic DNA, no temple control (NTC) and RT minus on the ABI 7900HT. The results ensured good amplification of cDNA, and that neither residual genomic DNA nor primer-dimer contributed to measurements.
###end p 54
###begin title 55
Genetic Association Study
###end title 55
###begin p 56
###xml 150 162 <span type="species:ncbi:9606">participants</span>
The local ethic committees (National Public Health Institute, Karolinska Institutet, and University of Umea) approved the study protocol, and all the participants signed an informed consent after the protocol had been fully explained.
###end p 56
###begin p 57
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-American1">[64]</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 354 361 <span type="species:ncbi:9606">patient</span>
###xml 363 371 <span type="species:ncbi:9606">Patients</span>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
###xml 410 413 <span type="species:ncbi:9606">men</span>
###xml 421 426 <span type="species:ncbi:9606">women</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
###xml 460 463 <span type="species:ncbi:9606">men</span>
###xml 471 476 <span type="species:ncbi:9606">women</span>
Patients were recruited from outpatient services at which senior specialists in psychiatry, familiar with our research program, were working. All patients met the DSM-IV diagnostic criteria for major depressive disorder with the seasonal (winter) pattern [64]. The consensus diagnosis of two independent psychiatrists was required for inclusion for each patient. Patients were from Sweden (118 patients: 13.6% men, 86.4% women) and Finland (86 patients: 29.1% men, 70.9% women), both being of local origin.
###end p 57
###begin p 58
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Lundberg1">[65]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Perl1">[67]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Luo1">[24]</xref>
###xml 67 70 <span type="species:ncbi:9606">men</span>
###xml 78 83 <span type="species:ncbi:9606">women</span>
###xml 107 110 <span type="species:ncbi:9606">men</span>
###xml 118 123 <span type="species:ncbi:9606">women</span>
Controls matched for ethnicity and nationality (1011 Swedes: 39.2% men, 60.8% women; and 1096 Finns: 29.0% men, 71.0% women) had no current or past psychotic or mood disorder as assessed with interviews or self-rated questionnaires and were representative of the Swedish and Finnish adult populations. These population-based studies have been described more in detail earlier [65]-[67]. The Swedish cases and controls lived in Vasterbotten and Stockholm areas. The Swedish population has no strong internal genetic borders [24]. The Finnish cases lived in the capital area (Helsinki and its surroundings), with inhabitants from all the regions in Finland, and the controls were collected from the nation-wide health examination study.
###end p 58
###begin title 59
Single-Nucleotide Polymorphism (SNP) Selection and Genotyping
###end title 59
###begin p 60
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-The1">[68]</xref>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Haplotype-tagging SNPs covering the variation in CRY2 were selected using the HapMap database [68], applying the cut-off values of 0.8 for r2 and of 0.1 for the minor allele frequency (MAF). The genotyping was performed using the SEQUENOM iPLEX Application with the MassARRAY System (Sequenom, Inc., San Diego, CA, USA). To control for quality, 2.5% of the samples were genotyped in duplicates. The genotypes of these replicas were all in agreement.
###end p 60
###begin p 61
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
The four CRY2 SNPs genotyped fulfilled the criteria for SNP association test including a success rate of at least 90% of the reactions, and the Hardy-Weinberg equilibrium (HWE) with P>0.05 among the controls. The DNA samples from 10 Swedish cases and 53 controls, and 5 Finnish cases and 24 controls were excluded from analysis, since genotyping of them failed in more than 20% of a separate set of 111 SNP assays.
###end p 61
###begin title 62
Statistical Analyses
###end title 62
###begin p 63
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1ORF82</italic>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFG</italic>
###xml 424 431 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1ORF82</italic>
###xml 436 439 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFG</italic>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Vandesompele1">[69]</xref>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 572 577 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 682 687 682 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
For the RNA analysis, the cycle threshold (Ct) was determined approximately in the middle of exponential phase of the amplification, and generally default condition on the software SDS 2.3 was used. The average Ct value was accepted if the CV was lower than 2% and SD was lower than 0.39. The Ct values for CRY2 and the house-keeping gene GAPDH were normalized using the housekeeping genes C1ORF82 and TFG. The selection of C1ORF82 and TFG and the normalization method was based on the GENORM [69]. Within each of the case and the control groups, correlation for CRY2 and GAPDH expression levels to age was tested and showed no significant correlation. Among controls, the CRY2 and GAPDH expression levels were compared between pre-sleep deprivation time points (pooled time points from #1 to #4) and sleep deprived time points (pooled time points from #6 to #9), where the individual was used as a factor in a mixed model ANOVA.
###end p 63
###begin p 64
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
CRY2 and GAPDH expression levels comparison between bipolar patients (time point 1 p.m.) and controls (pooled time points from #1 to #4, and from #6 to #9) was done using ANOVA with the covariates gender, age and sleep deprivation (yes/no). Significant effect in ANOVA (p<0.05) was followed-up with post hoc test.
###end p 64
###begin p 65
###xml 507 514 507 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009407-t001">Table 1</xref>
###xml 1183 1187 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Purcell1">[70]</xref>
###xml 178 183 <span type="species:ncbi:9606">women</span>
The SNPs were analyzed for allele frequency differences between the cases and controls in each population sample using logistic regression. Gender was used as a covariate, since women were overrepresented among Swedish cases compared with controls. To obtain empirical significance values, permutation tests with up to 10,000 permutations were performed. There was a similarity between the gender corrected effect size and the effect size when no gender was corrected for, especially in the Finnish sample (Table 1). Hence, the gender was not generally controlled for in the subsequent analyses. However, suggestive genotypic association findings in the Swedish sample were verified using logistic regression with the gender as a covariate, and displayed a very minor gender effect. The power was >/=0.8 to detect allele frequency differences at odds ratio (OR) of >/=1.8 in the Swedish sample and at OR of >/=2.0 in the Finnish sample when the MAF was of 0.1 to 0.3 and the non-corrected P was of <0.05 (). Those SNPs whose allele frequency difference was indicative (P<0.05) were analyzed for genotype association. Calculations were performed using the PLINK program, version 1.04 [70].
###end p 65
###begin p 66
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Barrett1">[71]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Qin1">[72]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009407-Gabriel1">[73]</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRY2</italic>
The linkage disequilibrium (LD) measure D' was calculated between the SNPs using the Haploview program, version 3.2 [71], which applies an approach similar to the partition-ligation-expectation-maximization algorithm [72]. Haplotype blocks were constructed using the LD block parameters [73], and the D' confidence interval algorithm in the Haploview program. Tests for haplotype frequency difference between the cases and controls were calculated for the haplotype blocks harboring the SNPs having P of <0.05 for allele association using the Haploview program. The SNP rs10838524 in CRY2 was included in haplotype analysis even though it was not included in any block but was nearby and associated as a single SNP with winter depression.
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin p 68
All the detected haplotypes of the CRY2 block.
###end p 68
###begin p 69
(0.04 MB DOC)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Circadian rhythm disturbances in depression.
###end article-title 72
###begin article-title 73
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock.
###end article-title 73
###begin article-title 74
Seasonal mood disorders: patterns of seasonal recurrence in mania and depression.
###end article-title 74
###begin article-title 75
Seasonal affective disorder.
###end article-title 75
###begin article-title 76
Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy.
###end article-title 76
###begin article-title 77
High concordance of bipolar I disorder in a nationwide sample of twins.
###end article-title 77
###begin article-title 78
###xml 25 28 <span type="species:ncbi:9606">man</span>
Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression.
###end article-title 78
###begin article-title 79
Circadian genes, rhythms and the biology of mood disorders.
###end article-title 79
###begin article-title 80
Antidepressant and circadian phase-shifting effects of light.
###end article-title 80
###begin article-title 81
Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality.
###end article-title 81
###begin article-title 82
Circadian rest-activity disturbances in seasonal affective disorder.
###end article-title 82
###begin article-title 83
###xml 40 48 <span type="species:ncbi:9606">children</span>
Circadian rest-activity disturbances in children with seasonal affective disorder.
###end article-title 83
###begin article-title 84
Biologic rhythm disorders, depression, and phototherapy: a new hypothesis.
###end article-title 84
###begin article-title 85
Seasonal affective disorder and season-dependent abnormalities of melatonin suppression by light.
###end article-title 85
###begin article-title 86
Pathophysiology of depression: role of sleep and the melatonergic system.
###end article-title 86
###begin article-title 87
The role of circadian clock genes in mental disorders.
###end article-title 87
###begin article-title 88
###xml 9 14 <span type="species:ncbi:9606">human</span>
Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins.
###end article-title 88
###begin article-title 89
mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop.
###end article-title 89
###begin article-title 90
Vitamin B2-based blue-light photoreceptors in the retinohypothalamic tract as the photoactive pigments for setting the circadian clock in mammals.
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 20 <span type="species:ncbi:7227">Drosophila</span>
Human and Drosophila cryptochromes are light activated by flavin photoreduction in living cells.
###end article-title 91
###begin article-title 92
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Electroretinography of wild-type and Cry mutant mice reveals circadian tuning of photopic and mesopic retinal responses.
###end article-title 92
###begin article-title 93
Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway.
###end article-title 93
###begin article-title 94
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
A subpopulation of efferent neurons in the mouse suprachiasmatic nucleus is also light responsive.
###end article-title 94
###begin article-title 95
Circuit projection from suprachiasmatic nucleus to ventral tegmental area: a novel circadian output pathway.
###end article-title 95
###begin article-title 96
Cryptochromes impair phosphorylation of transcriptional activators in the clock: a general mechanism for circadian repression.
###end article-title 96
###begin article-title 97
Population structure in contemporary Sweden - a Y-chromosomal and mitochondrial DNA analysis.
###end article-title 97
###begin article-title 98
###xml 84 89 <span type="species:ncbi:9606">human</span>
Phosphorylation of clock protein PER1 regulates its circadian degradation in normal human fibroblasts.
###end article-title 98
###begin article-title 99
###xml 49 54 <span type="species:ncbi:9606">human</span>
Circadian variations in clock gene expression of human bone marrow CD34+ cells.
###end article-title 99
###begin article-title 100
###xml 31 36 <span type="species:ncbi:9606">human</span>
Purification and properties of human blue-light photoreceptor cryptochrome 2.
###end article-title 100
###begin article-title 101
Proof-by-synthesis of the transcriptional logic of mammalian circadian clocks.
###end article-title 101
###begin article-title 102
A model of the cell-autonomous mammalian circadian clock.
###end article-title 102
###begin article-title 103
###xml 66 71 <span type="species:ncbi:9606">human</span>
A genome-wide RNAi screen for modifiers of the circadian clock in human cells.
###end article-title 103
###begin article-title 104
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses.
###end article-title 104
###begin article-title 105
Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms.
###end article-title 105
###begin article-title 106
Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2.
###end article-title 106
###begin article-title 107
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Effects of constant light on circadian rhythmicity in mice lacking functional cry genes: dissimilar from per mutants.
###end article-title 107
###begin article-title 108
Photolyase/cryptochrome blue-light photoreceptors use photon energy to repair DNA and reset the circadian clock.
###end article-title 108
###begin article-title 109
Intercellular coupling confers robustness against mutations in the SCN circadian clock network.
###end article-title 109
###begin article-title 110
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Disruption of mCry2 restores circadian rhythmicity in mPer2 mutant mice.
###end article-title 110
###begin article-title 111
Clock genes and the long-term regulation of prolactin secretion: evidence for a photoperiod/circannual timer in the pars tuberalis.
###end article-title 111
###begin article-title 112
A forced desynchrony study of circadian pacemaker characteristics in seasonal affective disorder.
###end article-title 112
###begin article-title 113
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Lithium effects on time estimation and mood in manic-melancholic patients: a study of diurnal variations.
###end article-title 113
###begin article-title 114
Assembling a clock for all seasons: are there M and E oscillators in the genes?
###end article-title 114
###begin article-title 115
Effects of morning phototherapy on circadian markers in seasonal affective disorder.
###end article-title 115
###begin article-title 116
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Melatonin suppression by light in euthymic bipolar and unipolar patients.
###end article-title 116
###begin article-title 117
###xml 42 50 <span type="species:ncbi:9606">patients</span>
A circadian signal of change of season in patients with seasonal affective disorder.
###end article-title 117
###begin article-title 118
Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.
###end article-title 118
###begin article-title 119
PER2 variantion is associated with depression vulnerability.
###end article-title 119
###begin article-title 120
The circadian basis of winter depression.
###end article-title 120
###begin article-title 121
The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis.
###end article-title 121
###begin article-title 122
Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms.
###end article-title 122
###begin article-title 123
Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach.
###end article-title 123
###begin article-title 124
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
###end article-title 124
###begin article-title 125
Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.
###end article-title 125
###begin article-title 126
Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia.
###end article-title 126
###begin article-title 127
Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet.
###end article-title 127
###begin article-title 128
Circadian polymorphisms associated with affective disorders.
###end article-title 128
###begin article-title 129
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference.
###end article-title 129
###begin article-title 130
Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood.
###end article-title 130
###begin article-title 131
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.
###end article-title 131
###begin article-title 132
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms.
###end article-title 132
###begin article-title 133
Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing.
###end article-title 133
###begin article-title 134
A rating scale for depression.
###end article-title 134
###begin article-title 135
Diagnostic and Statistical Manual of Mental Disorders, 4th ed.
###end article-title 135
###begin article-title 136
Determinants of non-participation, and the effects of non-participation on potential cause-effect relationships, in the PART study on mental disorders.
###end article-title 136
###begin article-title 137
DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-results from the Health 2000 Study.
###end article-title 137
###begin article-title 138
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
###end article-title 138
###begin article-title 139
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome.
###end article-title 139
###begin article-title 140
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
###end article-title 140
###begin article-title 141
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 141
###begin article-title 142
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 142
###begin article-title 143
Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms.
###end article-title 143
###begin article-title 144
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome.
###end article-title 144
###begin p 145
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Dr. Vawter is a co-founder of a diagnostic testing company AbaStar MDx, Dr. Kelsoe is consultant for AstraZeneca, on speakers bureau for Merck, and founder, board member and hold equity in diagnostic testing company Psynomics, all in compliance with UCSD guidelines. Dr. Bunney is a member of the scientific advisory boards of NeoSync, Inc., CNS Response, Inc. and Thuris Corporation and consultant for NeuDezine. None of these commercial affiliations played any role in this study.
###end p 145
###begin p 146
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 653 657 <span type="species:ncbi:9689">Lion</span>
Funding: This study was supported in part by grants from Academy of Finland (#201097 and #210262, ) and The Finnish Medical Foundation to Dr. Partonen, from Academy of Finland (#203425, ) and Helsinki University Central Hospital (TYH538) to Dr. Paunio, from the Swedish Research Council (2005-6245, 2006-4670, ), the Stockholm County Council (ALF, ) and Karolinska Institutet Foundations () to Drs. Lavebratt and Schalling, by Public Health Service research grant M01 RR00827 from the National Center for Research Resource () to UCI, Biomarker research grant MH 024370 to Dr. Vawter from the National Institute of Mental Health (), and from the William Lion Penzner Foundation to Drs. Vawter and Bunney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 146

